Trial intelligence / Profile preview

Very Low-volume Plasma Exchange in Acute-on-Chronic Liver Failure

NCT07857434Not yet recruiting

Sponsor
The Third Affiliated Hospital of Sun Yat-sen University
Start
Oct 2026
Primary completion
Nov 2028
01

Overview

Randomised, open-label trial in acute-on-chronic liver failure (ACLF) (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoint: 28-Day Non-Liver-Transplant Mortality. Planned start Oct 2026; status: not yet recruiting.

02

Conditions

acute-on-chronic liver failure (ACLF)

Beyond the preview

Go deeper on NCT07857434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07857434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call